PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 261 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $677,414 | -23.4% | 22,080 | 0.0% | 0.00% | -50.0% |
| Q2 2023 | $884,746 | -1.8% | 22,080 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $901,085 | +5.7% | 22,080 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $852,509 | -3.9% | 22,080 | +32.4% | 0.00% | 0.0% |
| Q3 2022 | $887,000 | -17.4% | 16,680 | -9.5% | 0.00% | -33.3% |
| Q2 2022 | $1,074,000 | -23.7% | 18,430 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $1,407,000 | +26.9% | 18,430 | 0.0% | 0.00% | +50.0% |
| Q4 2021 | $1,109,000 | -28.3% | 18,430 | -33.2% | 0.00% | -33.3% |
| Q3 2021 | $1,546,000 | -7.7% | 27,600 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $1,675,000 | -13.4% | 27,600 | 0.0% | 0.00% | -25.0% |
| Q1 2021 | $1,934,000 | +27.7% | 27,600 | +9.1% | 0.00% | +33.3% |
| Q4 2020 | $1,514,000 | +27.2% | 25,300 | +27.8% | 0.00% | 0.0% |
| Q3 2020 | $1,190,000 | +14.5% | 19,800 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $1,039,000 | +56.5% | 19,800 | 0.0% | 0.00% | +50.0% |
| Q1 2020 | $664,000 | +57.7% | 19,800 | +112.9% | 0.00% | +100.0% |
| Q4 2019 | $421,000 | – | 9,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |